We are live on ! Find out more
OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

52 hedge funds and large institutions have $312M invested in Singular Genomics Systems, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 6

6% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 18

0% more funds holding

Funds holding: 52 → 52 (0)

59% less capital invested

Capital invested by funds: $757M → $312M (-$445M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
52
Holders Change
–
Holders Change %
0%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
19
Increased
18
Reduced
6
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.8M
2
Millennium Management
Millennium Management
New York
+$4.15M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.03M
4
JP Morgan Chase
JP Morgan Chase
New York
+$2.98M
5
State Street
State Street
Massachusetts
+$1.97M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$13.7M
2
PVI
Pura Vida Investments
New York
-$4.29M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.96M
4
Goldman Sachs
Goldman Sachs
New York
-$2.06M
5
SFM
Sphera Funds Management
Israel
-$1.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$572K +$376K +734 +76%
PPA
27
Parametric Portfolio Associates
Washington
$422K +$645K +1,258 New
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$366K +$558K +1,089 New
CCM
29
CAAS Capital Management
New York
$336K – – –
Charles Schwab
30
Charles Schwab
California
$328K +$500K +976 New
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$304K +$95.4K +186 +26%
UBS Group
32
UBS Group
Switzerland
$233K +$355K +692 +23,067%
TFS
33
TrustCore Financial Services
Tennessee
$171K +$262K +510 New
N
34
Nuveen
North Carolina
$169K +$258K +504 New
GCM
35
Ghisallo Capital Management
Massachusetts
$168K +$85.6K +167 +50%
Two Sigma Investments
36
Two Sigma Investments
New York
$150K -$27.2K -53 -11%
Federated Hermes
37
Federated Hermes
Pennsylvania
$112K -$171K -334 -50%
Deutsche Bank
38
Deutsche Bank
Germany
$76K +$116K +227 New
AIG
39
American International Group
New York
$73K +$111K +216 New
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$72K +$109K +213 New
Morgan Stanley
41
Morgan Stanley
New York
$62K +$94.9K +185 +18,500%
Bank of America
42
Bank of America
North Carolina
$49K +$45.1K +88 +152%
SO
43
STRS Ohio
Ohio
$30K +$46.1K +90 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$27K +$22.1K +43 +119%
Citigroup
45
Citigroup
New York
$15K +$23.1K +45 New
Legal & General Group
46
Legal & General Group
United Kingdom
$12K +$10.3K +20 +118%
TRCT
47
Tower Research Capital (TRC)
New York
$11K +$16.9K +33 New
AIP
48
Ameritas Investment Partners
Nebraska
$10K +$15.4K +30 New
HI
49
Harbour Investments
Wisconsin
$2K – – –
Wells Fargo
50
Wells Fargo
California
$1K +$1.03K +2 New
1
2
3

OMIC Hedge Fund Activity: Q3 2021 in Review

52 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q3 2021, worth a combined $312M — down 59% from $757M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new OMIC positions and 18 closed out — a net gain of 1 holder — while 18 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $9.8M. The largest seller was Franklin Resources, exiting entirely with an estimated $13.7M sold.

  • 52 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $312M of Singular Genomics Systems, Inc. Common Stock stock for Q3 2021, down 59% quarter-over-quarter.
  • 19 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q3 2021 and 18 closed out, a net change of +1 holder.
  • The largest Singular Genomics Systems, Inc. Common Stock buyer in Q3 2021 was BlackRock, an estimated $9.8M added.
  • The largest Singular Genomics Systems, Inc. Common Stock seller in Q3 2021 was Franklin Resources, an estimated $13.7M sold.

Based on aggregated 13F filings for Q3 2021.